Glaukos Corporation Announces Launch of Initial Public Offering

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation, an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, announced today the launch of its initial public offering of 5,358,000 shares of its common stock. The initial public offering price is currently estimated to be between $13 and $15 per share. The underwriters for the offering will also have a 30-day option to

Print Friendly, PDF & Email

Share This

Share this post with your friends!